Working... Menu

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02581839
Recruitment Status : Active, not recruiting
First Posted : October 21, 2015
Last Update Posted : April 12, 2019
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : July 2, 2018
  Estimated Study Completion Date : July 2, 2020